Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1985-12-10
1989-10-03
Nucker, Christine M.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
435 7, 435 68, 43524027, 424 9, 424 858, 424 88, 436536, 436539, 436548, 436813, A61K 3900, G01N 33577
Patent
active
048718343
ABSTRACT:
A process for producing monoclonal antibodies specific to carcinoembryonic antigen (CEA), comprising immunizing a mammal with a first CEA to produce cells capable of producing antibodies, collecting the cells from the mammal, fusing the collected cells with the cells of a line of myeloma of another mammal, selecting the thus-obtained hybridoma cells on the basis of their capacity to produce antibodies reactive with said first CEA, subjecting the thus-selected hybridoma cells to cloning, selecting the thus-obtained monoclones on the basis of the reactivities of monoclonal antibodies produced by them with at least one antigen selected from CEAs other than said first CEA and CEA-related antigens of normal adult human origin, culturing the thus-obtained monoclones and recovering the desired monoclonal antibodies from the spent culture. The selection may preferably be effected by radioimmunoassay using a marker antigen labelled with a radioactive substance. Monoclonal anti-CEA antibodies thus-produced have specific reactivity with the antigenic determinants of CEA molecules and thus may with advantage be used for various clinical applications and fundamental medical studies such as, for example, for determination of the concentration of CEA and CEA-related antigens.
REFERENCES:
patent: 4140753 (1979-02-01), Edgington et al.
patent: 4145336 (1979-03-01), Edgington et al.
patent: 4180499 (1979-12-01), Hansen
patent: 4299815 (1981-11-01), Hansen et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4348376 (1982-09-01), Goldenberg
patent: 4349528 (1982-09-01), Koprowski et al.
Hedin, A. et al., Molecular Immunology, 19(12), 1641-1648, (1982).
Chemical Abstracts, I, 94:203339f, (1981).
Chemical Abstracts, II, 96:215704a, (1982).
Chemical Abstracts, III, 97:90148j, (1982).
Chemical Abstracts, IV, 98:32757s, (1983).
Kuroki et al.: Cancer Res., 41, 713-720, (1981).
Accolla et al.: Proc. Natl. Acad., Sci., U.S.A., 77, 563, (1980).
Mitchell, K. F., Cancer Immunol. Immunother., 10, 1, (1980).
Rogers, G. T. et al.: Br. J. Cancer, 43, 1, (1981).
Kupchik, H. Z. et al., Cancer Res., 41, 3306, (1981).
Kuroki et al., (see item No. 1 above).
Molecular Immunology, 19, 399, (1982).
Kuroki Masahide
Matsuoka Yuji
LandOfFree
Monoclonal antibodies specific to CEA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies specific to CEA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies specific to CEA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-665233